期刊文献+

非小细胞肺癌患者组织、血清白介素及血管内皮细胞生长因子的变化 被引量:2

Change of tissue and serum interleukin and vascular endothelial growth factor of patients with nonsmall-cell lung cancer
下载PDF
导出
摘要 目的:分析非小细胞肺癌患者组织、血清白介素及血管内皮细胞生长因子的变化情况。方法:选取2013年1月-2014年4月本院收治的100例非小细胞肺癌患者为观察组,同期的100例肺部良性病变患者为对照组,比较两组组织、血清白介素及血管内皮生长因子水平,同时比较观察组中不同分期患者的检测结果。结果:观察组组织、血清白介素及血管内皮生长因子指标均明显高于对照组,且观察组中分期较高者各指标水平均明显高于分期较低者,差异均有统计学意义(P均〈0.05)。结论:非小细胞肺癌患者组织、血清白介素及血管内皮细胞生长因子均呈现高表达状态,且分期越高的肺癌患者其上述指标的表达水平越高。 Objective: To study the change situation of tissue and serum interleukin and vascular endothelial growth fac- tor of patients with nonsmall-cell lung cancer. Methods: 100 patients with nonsmall-cell lung cancer in our hospital from Januar- y 2013 to April 2014 were selected as observation group,then 100 patients with benign lung disease at the same time were se- lected as control group. Tissue and serum interleukin and vascular endothelial growth factor of two groups were compared, and the detection results of observation group with different stages were compared too. Results: The tissue and serum interleukin and vascular endothelial growth factor of observation group were all obviously higher than those of control group, the tissue and serum interleukin and vascular endothelial growth factor of observation group with higher stages were all significantly higher than those of patients with lower stages (all P〈0.05). Conclusion:Interleukin and vascular endothelial growth factor are high- ly expressed in issue and serum of patients with nonsmall-cell lung cancer, and those indexes of patients with higher stage of lung cancer show higher exoression levels.
出处 《海南医学院学报》 CAS 2014年第9期1265-1266,1269,共3页 Journal of Hainan Medical University
基金 陕西省科技攻关项目(2011K12-15)~~
关键词 非小细胞肺癌 组织 血清 白介素 血管内皮细胞生长因子 Nonsmall-cell lung cancer Tissue Serum Interleukin Vascular endothelial growth factor
  • 相关文献

参考文献10

二级参考文献102

  • 1胡瑛,李宝兰,宋长兴.非小细胞肺癌患者术后血清VEGF、MMP-9动态变化的研究[J].中国肺癌杂志,2008,11(5):734-738. 被引量:9
  • 2柳兴其,陈检芳.肺癌患者治疗前后血清白细胞介素-6、肿瘤坏死因子和血管内皮生长因子水平及其临床意义[J].中国现代医学杂志,2006,16(18):2776-2778. 被引量:17
  • 3周志伟,莫海山,梁晖.肺癌患者血清白细胞介素6,8,18的测定及其临床意义[J].肿瘤研究与临床,2006,18(11):739-741. 被引量:9
  • 4Fujiwara T,Nishizaki M,Tanaka N,et al.Recombinant adenovirus expressing wild-type p53 is antiangiogenic-implication for lung cancergene therapy[J].Gan To Kagaku Ryoho,2000,27(8):1217-1224.
  • 5Koukourakis MI,Giatromanolaki A,O'Byrne KJ,et al.Bcl22 and cerbB22 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in none small cell lung cancer[J].Clin Exp Metastas,1999,17(7):545-554.
  • 6Fontaning G,Vignati S,Bigini D,et al.Epidermal growth factor receptor expression in non-small cell lung carcinomas correlates with metastatic involvement of hilarand mediastinal lymph nodes in the squamous subtype[J].Int J Cancer,1996,67:615-617.
  • 7Linderholm BK,Lindahl T,Holmberg L,et al.The expression of vascular endothelial growth factorcor relates with mutant p53 and poor prognosis in human breast cancer[J].Cancer Res,2001,61(5):2256-2260.
  • 8Bouvet M,Ellis LM,Nishizaki M,et al.Adenovirus-mediated wild-type p53 gene t ra nsf er down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer[J].Cancer Res,1998,58(6):2288-2292.
  • 9Gautam A,Densmore CL,Melton S,et al.Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis[J].Cancer Gene Ther,2002,9(1):28-32.
  • 10Segawa Y,Kageyama M,Suzuki S,et al.Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation:a prospective study[J].Br J Cancer,1998,78 (5):667-672.

共引文献64

同被引文献23

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部